Indeed, IL-1 receptor antagonist or Anakinra (Kineret) is an FDA-approved treatment for human rheumatoid arthritis [39] and Il1rn deficiency in mice results in spontaneous polyarthropathies [40]. Here, IL1RN is linked to arthritic joint disease.